The Future of Psychedelic Medicine
Our Story
Find out what inspires us to support mental health disorders.
Our Mission
Supporting innovative therapies to help humans thrive.
Our Team
Multi-Disciplinary Collaboration
creating positive experiences and outcomes.
Mission
Using a foundation of evidence-informed research, we want to empower people to achieve their potential and thrive.
CORE PILLARS
HAVN Labs
- Havn Labs will support innovative therapies addressing human health through the development of methods for standardization and the extraction of quality-controlled compounds derived from plants and fungi.
Psychedelic medicine is the frontier of mental health and wellness
Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.
350 Million
People globally are affected by a form of depression.
1 Trillion
Dollars lost annually in global workforce productivity due to depression and anxiety.
0
Formulas standardized across clinical studies of psychedelic compounds.
Havn Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.
Havn Life Sciences to support the first modern psilocybin depression study in Germany with MIND Foundation
The research will be led by Prof. Dr. Gerhard Gründer, the only confirmed scientist developing a study to work with psychedelics in Germany since the …
Havn Life Sciences earns Health Canada approval for natural health product formulations
The initial six approved formulations were developed to enhance human performance and cognitive health Vancouver, BC – Havn Life Sciences Inc. (CSE : HAVN) (FSE …
Havn Life Sciences signs agreement to supply psychedelic compounds for use in research and development to Revive Therapeutics
Havn Life will export naturally derived psilocybin to the United States, for use in IND-enabling studies and future clinical trials under FDA guidelines Vancouver, BC …